TB-500
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
TB-500 ist ein synthetisches Peptid, das der aktiven Region von Thymosin Beta-4 entspricht, einem natürlich vorkommenden Protein, das einer der primären Regulatoren des zytoskelettalen Proteins Aktin ist. Da Aktin-Dynamiken Zellmigration, Wundverschluss und Blutgefäßwachstum zugrunde liegen, ist TB-500 eine zentrale Werkzeugverbindung in der Gewebereparatur- und Regenerationsforschung.
| Test | Result | Status |
|---|---|---|
| Purity | 99.171% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.931% | Passed ✓ |
Research Information
TB-500 wird auf seine Regulation der Aktin-Polymerisation, Zellmigration, Angiogenese und die Rekrutierung von Reparaturzellen zu verletztem Gewebe in Wundheilungs- und Regenerationsmodellen untersucht. Es wird häufig zusammen mit BPC-157 untersucht, wobei Forscher prüfen, ob die beiden Peptide durch komplementäre Reparaturmechanismen wirken. Wird ausschließlich für In-vitro- und Laborforschungszwecke geliefert – nicht für den menschlichen oder tierischen Verzehr.
TB-500 Research & Studies
What is TB-500?
TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein that serves as one of the primary regulators of the cytoskeletal protein actin. In laboratory research it functions as a tool compound for examining how actin dynamics influence cell migration, wound closure, and blood-vessel growth. Investigators employ TB-500 to isolate and study this functional domain within controlled in-vitro and experimental tissue-repair systems.
Mechanism of Action
Research on TB-500 focuses on its capacity to regulate actin polymerization, a core process that maintains cellular architecture and enables motility. Experimental models explore how modulation of actin dynamics supports cell migration and the directed recruitment of repair-associated cells. These investigations also examine related pathways that contribute to tissue remodeling and angiogenic responses under laboratory conditions.
Primary Areas of Research
TB-500 is studied principally in wound-healing and regeneration models that assess actin-dependent cellular repair mechanisms. Key areas of inquiry include angiogenesis, cell migration, and the orchestration of repair-cell recruitment to sites of experimental injury. The peptide is frequently examined alongside BPC-157 so that researchers can evaluate whether the two compounds engage complementary pathways in tissue-repair frameworks.
Key Research Findings
Laboratory work has shown that TB-500 influences actin-related processes underlying cell movement and structural reorganization. Observations from model systems indicate effects on pathways linked to blood-vessel growth and the cellular responses associated with tissue repair. All such findings remain confined to controlled experimental contexts and contribute to the broader study of cytoskeletal regulation in regenerative biology.
Research Handling & Considerations
TB-500 is supplied strictly for in-vitro and laboratory research use only and is not intended for human or animal consumption. Standard peptide-handling practices apply, including appropriate storage and reconstitution methods that preserve stability for experimental work. Researchers must follow institutional biosafety and laboratory protocols when incorporating this compound into model systems.
Frequently Asked Questions
TB-500 is a synthetic peptide that corresponds to the active region of the naturally occurring protein Thymosin Beta-4. It allows researchers to study the functional properties of that region in isolation within experimental systems.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.
Explore Other High-Purity Peptides
BPC-157
KPV
Cartalax
